We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-2.97%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$107B
AUM Growth
-$4.88B
(-4.4%)
Cap. Flow
+$802M
Cap. Flow
% of AUM
0.75%
Top 10 Holdings %
Top 10 Hldgs %
28.03%
Holding
4,262
New
46
Increased
1,724
Reduced
2,093
Closed
87
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares Russell 2000 ETF
IWM
|
+$78.7M |
| 2 |
XYZ
Block Inc
XYZ
|
+$49.3M |
| 3 |
Visa
V
|
+$46.1M |
| 4 |
Apple
AAPL
|
+$45.4M |
| 5 |
DoorDash
DASH
|
+$45.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Meta Platforms (Facebook)
META
|
+$78.8M |
| 2 |
EXE
Expand Energy Corp
EXE
|
+$23.2M |
| 3 |
Williams-Sonoma
WSM
|
+$22.2M |
| 4 |
Broadcom
AVGO
|
+$20.3M |
| 5 |
AZPN
Aspen Technology Inc
AZPN
|
+$19.7M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 28.67% |
| 2 | Financials | 14.43% |
| 3 | Healthcare | 10.97% |
| 4 | Consumer Discretionary | 10.82% |
| 5 | Industrials | 8.93% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
GRVY
3126
GRAVITY
GRVY
$473M
| $87.6K | ﹤0.01% |
1,448
-991
| -41% | -$59.3K |
|
3127
Atossa Therapeutics
ATOS
$23.5M
| $87.4K | ﹤0.01% |
8,657
+509
| +6% | +$6.18K |
|
3128
InfuSystem Holdings
INFU
$249M
| $86.9K | ﹤0.01% |
16,157
+546
| +3% | +$3.99K |
|
3129
InnovAge Holding
INNV
$1.52B
| $86.7K | ﹤0.01% |
29,108
-886
| -3% | -$3.06K |
|
|
GRFS
3130
Grifois
GRFS
$5.4B
| $86.6K | ﹤0.01% |
12,176
-4,946
| -29% | -$37.3K |
|
3131
Biomea Fusion
BMEA
$91.3M
| $86.2K | ﹤0.01% |
40,477
+3,043
| +8% | +$10.4K |
|
3132
Gyre Therapeutics
GYRE
$744M
| $86K | ﹤0.01% |
11,141
+709
| +7% | +$7.78K |
|
3133
iShares MSCI Italy ETF
EWI
$1.07B
| $85.5K | ﹤0.01% |
2,020
| – | – |
|
3134
Cabaletta Bio
CABA
$455M
| $85K | ﹤0.01% |
61,388
-2,033
| -3% | -$4.33K |
|
3135
Black Diamond Therapeutics
BDTX
$112M
| $85K | ﹤0.01% |
54,836
-1,299
| -2% | -$2.72K |
|
3136
Twin Disc
TWIN
$348M
| $84.6K | ﹤0.01% |
11,171
-427
| -4% | -$4.15K |
|
|
MAG
3137
DELISTED
MAG Silver
MAG
| $83.5K | ﹤0.01% |
5,463
-408
| -7% | -$6.33K |
|
3138
Geospace Technologies
GEOS
$75.7M
| $83.3K | ﹤0.01% |
11,559
-1,578
| -12% | -$13.5K |
|
3139
ENI
E
$77.5B
| $82.2K | ﹤0.01% |
2,659
| – | – |
|
|
KWY
3140
Kingsway Corp
KWY
$293M
| $81.8K | ﹤0.01% |
10,327
-1,777
| -15% | -$14K |
|
|
UPB
3141
Upstream Bio Inc
UPB
$395M
| $81.6K | ﹤0.01% |
13,327
-3,394
| -20% | -$32.4K |
|
3142
Stereotaxis
STXS
$141M
| $80.9K | ﹤0.01% |
45,997
+2,763
| +6% | +$5.89K |
|
3143
Corbus Pharmaceuticals
CRBP
$190M
| $80.4K | ﹤0.01% |
15,139
+25
| +0.2% | +$221 |
|
3144
BCE
BCE
$21.2B
| $80.3K | ﹤0.01% |
3,496
-260
| -7% | -$6.12K |
|
3145
Sutro Biopharma
STRO
$421M
| $79.9K | ﹤0.01% |
12,282
-388
| -3% | -$6.11K |
|
|
MAZE
3146
Maze Therapeutics
MAZE
$1.59B
| $79.7K | ﹤0.01% |
+7,235
| New | +$87.1K |
|
3147
1stdibs.com
DIBS
$171M
| $79.3K | ﹤0.01% |
26,079
+2,837
| +12% | +$10.2K |
|
3148
Rogers Communications
RCI
$18.6B
| $79.2K | ﹤0.01% |
2,963
-206
| -7% | -$5.82K |
|
3149
Cemex
CX
$16.3B
| $77.9K | ﹤0.01% |
13,880
-3,019
| -18% | -$18.3K |
|
3150
Traeger
COOK
$172M
| $77.7K | ﹤0.01% |
925
-80
| -8% | -$8.86K |
|
Similar funds
VAM
RhumbLine Advisers's Q1 2025 Portfolio in Review
As of Q1 2025, RhumbLine Advisers held 4,262 positions worth $107B, down 4.4% from $112B the previous quarter. Its ten largest holdings account for 28% of the portfolio.
Trading was light in Q1 2025: portfolio turnover was 3.1%. RhumbLine Advisers opened 46 new positions and exited 87, leaving the 4,262-position portfolio largely intact.
By sector, the portfolio is most concentrated in Technology at 29% of assets, down from 31% a quarter earlier, followed by Financials and Healthcare.
- RhumbLine Advisers's largest Q1 2025 buy was Block Inc: 660,293 shares worth $35.9M.
- RhumbLine Advisers added most to iShares Russell 2000 ETF in Q1 2025, an estimated $78.7M increase.
- RhumbLine Advisers's biggest Q1 2025 reduction was Meta Platforms (Facebook), cutting an estimated $78.8M.
- RhumbLine Advisers fully exited Aspen Technology Inc in Q1 2025, selling an estimated $19.7M.
- RhumbLine Advisers's ten largest holdings make up 28% of its $107B portfolio in Q1 2025.
- RhumbLine Advisers opened 46 new positions and closed 87 in Q1 2025.
- RhumbLine Advisers's portfolio value fell 4.4% quarter-over-quarter to $107B.
Based on RhumbLine Advisers's 13F filing for Q1 2025, filed 8 Apr 2025.